BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19708980)

  • 21. [Chronic complication of diabetes and homocysteine].
    Idzior-Waluś B; Cieślik G
    Przegl Lek; 2000; 57(12):732-5. PubMed ID: 11398598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse effects of hyperhomocysteinemia and their management by folic acid.
    Perna AF; De Santo NG; Ingrosso D
    Miner Electrolyte Metab; 1997; 23(3-6):174-8. PubMed ID: 9387111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperhomocysteinemia in chronic renal failure: alternative therapeutic strategies.
    Perna AF; Sepe I; Lanza D; Pollastro RM; De Santo NG; Ingrosso D
    J Ren Nutr; 2012 Jan; 22(1):191-4. PubMed ID: 22200441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stroke: roles of B vitamins, homocysteine and antioxidants.
    Sánchez-Moreno C; Jiménez-Escrig A; Martín A
    Nutr Res Rev; 2009 Jun; 22(1):49-67. PubMed ID: 19555518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperhomocysteinemia and macromolecule modifications in uremic patients.
    Perna AF; Capasso R; Lombardi C; Acanfora F; Satta E; Ingrosso D
    Clin Chem Lab Med; 2005; 43(10):1032-8. PubMed ID: 16197294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homocysteine and coronary heart disease.
    Clarke R; Lewington S
    Semin Vasc Med; 2002 Nov; 2(4):391-9. PubMed ID: 16222629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Homocysteine--risk factor or risk indicator?].
    Rafflenbeul W
    MMW Fortschr Med; 2005 Nov; 147(44):28-30. PubMed ID: 16302487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic consequences of hyperhomocysteinemia in uremia.
    Perna AF; Ingrosso D; Satta E; Romano M; Cimmino A; Galletti P; Zappia V; De Santo NG
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S85-90. PubMed ID: 11576929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Increase of homocysteine in cardiovascular diseases in Hungary].
    Balogh E; Czuriga I; Bereczky Z; Boda K; Koszegi Z; Kónya C; Császár A; Muszbek L; Edes I; Ferdinandy P
    Orv Hetil; 2006 Sep; 147(35):1685-90. PubMed ID: 17051744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of B vitamins status and homocysteine levels in elderly Taiwanese.
    Chen KJ; Pan WH; Yang FL; Wei IL; Shaw NS; Lin BF
    Asia Pac J Clin Nutr; 2005; 14(3):250-5. PubMed ID: 16169836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications.
    Perna AF; Ingrosso D; Castaldo P; De Santo NG; Galletti P; Zappia V
    Miner Electrolyte Metab; 1999; 25(1-2):95-9. PubMed ID: 10207268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of vitamins B6, B12 and folic acid on hyperhomocysteinemia in a Pakistani population of patients with acute myocardial infarction.
    Iqbal MP; Ishaq M; Kazmi KA; Yousuf FA; Mehboobali N; Ali SA; Khan AH; Waqar MA
    Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):100-8. PubMed ID: 15871858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of hyperhomocysteinemia.
    Herrmann W
    Clin Lab; 2006; 52(7-8):367-74. PubMed ID: 16955635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamins and minerals 4: overview of folate and the B vitamins.
    Thompson J
    Community Pract; 2006 Jun; 79(6):197-8. PubMed ID: 16780289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
    Austin RC; Lentz SR; Werstuck GH
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S56-64. PubMed ID: 15243582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: implications for mechanism.
    Perna AF; Castaldo P; De Santo NG; di Carlo E; Cimmino A; Galletti P; Zappia V; Ingrosso D
    Kidney Int; 2001 Jun; 59(6):2299-308. PubMed ID: 11380834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia.
    Ingrosso D; Cimmino A; Perna AF; Masella L; De Santo NG; De Bonis ML; Vacca M; D'Esposito M; D'Urso M; Galletti P; Zappia V
    Lancet; 2003 May; 361(9370):1693-9. PubMed ID: 12767735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperhomocysteinemia and cardiovascular disease in animal model.
    Azad MAK; Huang P; Liu G; Ren W; Teklebrh T; Yan W; Zhou X; Yin Y
    Amino Acids; 2018 Jan; 50(1):3-9. PubMed ID: 29018979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.